Fred E Dutton

Title: Fred E. Dutton: A Pioneer in Pharmaceutical Innovations

Introduction: Fred E. Dutton, based in Kalamazoo, MI, is a notable inventor with a significant contribution to the field of pharmaceuticals. With a total of three patents to his name, Dutton has focused on developing novel compounds that address critical health issues.

Latest Patents: Dutton's most recent inventions include cycloanthelmintic inhibitors, which are designed to inhibit the growth of helminths through specific chemical structures. The structural formula as per the specification outlines the unique configurations of the compounds. Additionally, he developed N-imidoylthio(methyl)carbamates, which pertain to a new class of organic compounds, along with a process for their preparation and formulations for pesticidal use, specifically targeting imidic acid derivatives of N-thio(methyl)carbamates.

Career Highlights: Dutton has had a distinguished career working with prominent companies in the pharmaceutical industry. He has been associated with The Upjohn Company and Pharmacia & Upjohn Company, where he played a vital role in advancing drug development and innovation. His contributions have been pivotal in the growth of these organizations.

Collaborations: Throughout his career, Dutton has collaborated with talented individuals, including Stephen J. Nelson and Byung H. Lee. These partnerships have fostered a collaborative environment that has led to significant advancements in his research and patent endeavors.

Conclusion: Fred E. Dutton remains a prominent figure in the field of pharmaceutical innovations. With his inventive spirit and collaborative efforts, he continues to contribute to the advancement of medical science through his significant patents and ongoing research. His work marks an essential step towards improving health and combating diseases.